Brief Amici Curiae of 82 Law, Economics, Business, and Medical Professors in Support of Respondent

M. Carrieret al., here. 

Hearing on Exploring the Effects of Consolidation and Anticompetitive Conduct in Health Care Markets

Video here. 

California could be first state to bar drug makers from paying competitors to delay release

LATimes, here. 

Supreme Court declines to review pay-for-delay ruling

Reuters, here.

CMA opens four new pharma antitrust probes

Slaughter and May, here.

EC sends Statement of Objections to Teva on 'pay for delay' pharma agreement

EC, Press Release, here. 

Intellectual Property Arrangements: Inquiry Report

Productivity Commission, here. 

EU Court Confirms European Commission’s Decision on Pay-for-Delay Agreement

McDermott, here.

Boehringer ordered to turn over documents in antitrust probe

Reuters, here.

Competition for a Fairer Society

M. Vestager, here.

"Here in the United States, the Council of Economic Advisors has warned about the risks of markets that are increasingly dominated by a few large companies".

More on Lundbeck v Commission: some comments on the comments #ourreadersask

P. Ibanez Colomo, here. 

General Court’s pay for delay judgment in Lundbeck – some guidance, but worries remain

S. Gallasch, here. 

GC Judgment in Case T-472/13, Lundbeck v Commission: on patents and Schrödinger’s cat

P. Ibanez Colomo, here.

Lundbeck Loses Appeal Against ‘Pay-For-Delay’ Decision

Covington, here. 

GC: Lundbeck confirmed

T‑472/13, here.
"The ‘scope of the patent’ test is...based on a subjective assessment, by the applicants, of the scope of their patents and of their validity, whereas a national court or competent authority may have taken a different view" (491).

Reverse Payments: An EU and US Perspective

F. Maier-Rigaud, N. Bialock, O. Gannon, here.

Quo Vadis FTC? (Endo Complaint)

D. Goldstein, R. Reznick, here. 

FTC Sues Endo Pharmaceuticals Inc. and Others for Illegally Blocking Lower-Cost Generic Versions of the Branded Drugs Opana ER and Lidoderm

Press Release, here. 

'Pay for delay' fined in the UK

CMA, here.

Drug Wars:A New Generation of Generic Pharmaceutical Delay

R. Feldman, E. Frondorf, here.